Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000731226 | SCV000859013 | uncertain significance | not provided | 2017-12-28 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002507295 | SCV002814266 | uncertain significance | Alagille syndrome due to a NOTCH2 point mutation; Hajdu-Cheney syndrome | 2021-07-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003353010 | SCV004077738 | uncertain significance | Inborn genetic diseases | 2023-09-13 | criteria provided, single submitter | clinical testing | The c.7342G>T (p.A2448S) alteration is located in exon 34 (coding exon 34) of the NOTCH2 gene. This alteration results from a G to T substitution at nucleotide position 7342, causing the alanine (A) at amino acid position 2448 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Invitae | RCV003633539 | SCV004534969 | likely benign | Hajdu-Cheney syndrome | 2023-02-14 | criteria provided, single submitter | clinical testing |